Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematological malignancies, suggesting the importance of RNA splicing in cancer. We analyzed whole-exome sequencing data across 33 tumor types in The Cancer Genome Atlas (TCGA), and we identified 119 splicing factor genes with significant non-silent mutation patterns, including mutation over-representation, recurrent loss of function (tumor suppressor-like), or hotspot mutation profile (oncogene-like). Furthermore, RNA sequencing analysis revealed altered splicing events associated with selected splicing factor mutations. In addition, we were able to identify common gene pathway profiles associated with the presence of these mutations. Our analysis s...
<div><p>Although recurrent somatic mutations in the splicing factor <i>U2AF1</i> (also known as <i>U...
It is increasingly appreciated that alternative splicing plays a key role in generating functional s...
We analyze RNA and whole exome sequencing data of tumors from 8,705 donors spanning a range of 32 ca...
Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematolo...
Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematolo...
Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory ele...
Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been i...
Somatic mutations reported in large-scale breast cancer (BC) sequencing studies primarily consist of...
Pre-mRNA splicing is a highly regulated step during gene expression and has been shown to be commonl...
Splicing abnormality resulting from somatic mutations in key splicing factor genes (SFG) has been de...
Non-coding mutations can create splice sites, however the true extent of how such somatic non-coding...
Transcript alterations often result from somatic changes in cancer genomes1. Various forms of RNA al...
Transcript alterations often result from somatic changes in cancer genomes. Various forms of RNA alt...
Dysregulation of alternative splicing (AS) is one of the molecular hallmarks of cancer, with splicin...
The recent genomic characterization of cancers has revealed recurrent somatic point mutations and co...
<div><p>Although recurrent somatic mutations in the splicing factor <i>U2AF1</i> (also known as <i>U...
It is increasingly appreciated that alternative splicing plays a key role in generating functional s...
We analyze RNA and whole exome sequencing data of tumors from 8,705 donors spanning a range of 32 ca...
Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematolo...
Hotspot mutations in splicing factor genes have been recently reported at high frequency in hematolo...
Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory ele...
Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been i...
Somatic mutations reported in large-scale breast cancer (BC) sequencing studies primarily consist of...
Pre-mRNA splicing is a highly regulated step during gene expression and has been shown to be commonl...
Splicing abnormality resulting from somatic mutations in key splicing factor genes (SFG) has been de...
Non-coding mutations can create splice sites, however the true extent of how such somatic non-coding...
Transcript alterations often result from somatic changes in cancer genomes1. Various forms of RNA al...
Transcript alterations often result from somatic changes in cancer genomes. Various forms of RNA alt...
Dysregulation of alternative splicing (AS) is one of the molecular hallmarks of cancer, with splicin...
The recent genomic characterization of cancers has revealed recurrent somatic point mutations and co...
<div><p>Although recurrent somatic mutations in the splicing factor <i>U2AF1</i> (also known as <i>U...
It is increasingly appreciated that alternative splicing plays a key role in generating functional s...
We analyze RNA and whole exome sequencing data of tumors from 8,705 donors spanning a range of 32 ca...